Development of Memory-Enhancing Agents in the Treatment of Alzheimer's Disease, Journal of the American Geriatrics Society, vol.37, issue.10, pp.957-958, 1987. ,
DOI : 10.1038/clpt.1985.54
The Statistical Modeling of Aging and Risk of Transition Project: Data Collection and Harmonization Across 11 Longitudinal Cohort Studies of Aging, Cognition, and Dementia, Obs. Stud, vol.1, pp.56-73, 2015. ,
Transcriptional dysregulation of 5-HT1A autoreceptors in mental illness, Molecular Brain, vol.4, issue.1, 2011. ,
DOI : 10.1523/JNEUROSCI.2409-10.2010
Executive functions in clinical and preclinical Alzheimer's disease, Revue Neurologique, vol.169, issue.10, pp.695-708, 2013. ,
DOI : 10.1016/j.neurol.2013.07.020
Structural brain alterations in heart failure: a review of the literature and implications for risk of Alzheimer???s disease, Heart Failure Reviews, vol.2013, issue.8, pp.561-571, 2015. ,
DOI : 10.1093/brain/awp105
An English translation of Alzheimer's 1907 paper Clin, 1995. ,
Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer???s disease, Neurobiology of Aging, vol.30, issue.8, pp.1192-1204, 2009. ,
DOI : 10.1016/j.neurobiolaging.2007.11.010
Combination of memantine and vitamin D prevents axon degeneration induced by amyloid-beta and glutamate, Neurobiology of Aging, vol.35, issue.2, pp.331-335, 2014. ,
DOI : 10.1016/j.neurobiolaging.2013.07.029
URL : https://hal.archives-ouvertes.fr/hal-01544168
Synaptic degeneration in Alzheimer???s disease, Acta Neuropathologica, vol.145, issue.2, pp.167-179, 2009. ,
DOI : 10.1001/archneur.1994.00540200048015
Tau and tauopathies, Brain Research Bulletin, vol.126, 2016. ,
DOI : 10.1016/j.brainresbull.2016.08.018
ADAM-10 over-expression increases cortical synaptogenesis, Neurobiology of Aging, vol.29, issue.4, pp.554-565, 2008. ,
DOI : 10.1016/j.neurobiolaging.2006.11.004
Detecting early preclinical Alzheimer's disease via cognition, neuropsychiatry, and neuroimaging: qualitative review and recommendations for testing, J. Alzheimers Dis. JAD, vol.42, pp.375-382, 2014. ,
Fluorinated benzophenone derivatives: Balanced multipotent agents for Alzheimer's disease, European Journal of Medicinal Chemistry, vol.78, pp.157-166, 2014. ,
DOI : 10.1016/j.ejmech.2014.03.042
Galantamine Slows Down Plaque Formation and Behavioral Decline in the 5XFAD Mouse Model of Alzheimer???s Disease, PLoS ONE, vol.40, issue.2, p.89454, 2014. ,
DOI : 10.1371/journal.pone.0089454.g007
Benzodiazepine use and risk of Alzheimer's disease: case-control study, BMJ, vol.349, issue.sep09 2, p.5205, 2014. ,
DOI : 10.1136/bmj.g5205
Pharmacological characterization of 5- hydroxytryptamine4(5-HT4) receptors positively coupled to adenylate cyclase in adult guinea pig hippocampal membranes: effect of substituted benzamide derivatives, Mol. Pharmacol, vol.37, pp.408-411, 1990. ,
5-HT4 receptors: History, molecular pharmacology and brain functions, Neuropharmacology, vol.55, issue.6, pp.922-931, 2008. ,
DOI : 10.1016/j.neuropharm.2008.05.013
Exposure to psychotropics in the French older population living with dementia: a nationwide population-based study, International Journal of Geriatric Psychiatry, vol.169, issue.180, 2016. ,
DOI : 10.1001/archinternmed.2009.357
URL : https://hal.archives-ouvertes.fr/hal-01545499
Aging and Memory in Humans, Encyclopedia of Neuroscience, pp.175-180, 2009. ,
DOI : 10.1016/B978-008045046-9.00745-2
Human secreted tau increases amyloid-beta production, Neurobiology of Aging, vol.36, issue.2, pp.693-709, 2015. ,
DOI : 10.1016/j.neurobiolaging.2014.09.007
URL : http://doi.org/10.1016/j.neurobiolaging.2014.09.007
Cardiovascular risk factors and future risk of Alzheimer???s disease, BMC Medicine, vol.53, issue.1, p.130, 2014. ,
DOI : 10.1046/j.1365-2265.2000.01146.x
Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats, Neurobiology of Learning and Memory, vol.96, issue.2, pp.392-402, 2011. ,
DOI : 10.1016/j.nlm.2011.06.015
Synaptic deficits in layer 5 neurons precede overt structural decay in 5xFAD mice, Neuroscience, vol.254, pp.152-159, 2013. ,
DOI : 10.1016/j.neuroscience.2013.09.016
receptor agonists increase sAPP?? levels in the cortex and hippocampus of male C57BL/6j mice, British Journal of Pharmacology, vol.90, issue.7, pp.883-892, 2007. ,
DOI : 10.3748/wjg.v9.i9.2065
Prucalopride and donepezil act synergistically to reverse scopolamine-induced memory deficit in C57Bl/6j mice, Behavioural Brain Research, vol.187, issue.2, pp.455-461, 2008. ,
DOI : 10.1016/j.bbr.2007.10.008
Treatment of Cognitive Deficits in Alzheimer's disease: A psychopharmacological review, Psychiatr. Danub, vol.28, pp.2-12, 2016. ,
Interactions of AChE with A? Aggregates in Alzheimer's Brain: Therapeutic Relevance of IDN 5706, Front. Mol. Neurosci, vol.4, 2011. ,
Alzheimer Disease, Disease-a-Month, vol.56, issue.9, pp.484-546, 2010. ,
DOI : 10.1016/j.disamonth.2010.06.001
A 10-year perspective on donepezil, Expert Opinion on Pharmacotherapy, vol.39, issue.5, pp.331-338, 2013. ,
DOI : 10.1002/gps.811
Disturbed Neurotransmitter Transporter Expression in Alzheimer???s Disease Brain, Journal of Alzheimer's Disease, vol.26, issue.4, pp.755-766, 2011. ,
DOI : 10.3233/JAD-2011-110002
The Cognitive Architecture of Spatial Navigation: Hippocampal and Striatal Contributions, Neuron, vol.88, issue.1, pp.64-77, 2015. ,
DOI : 10.1016/j.neuron.2015.09.021
Genetics of Alzheimer???s Disease, Adv. Genet, vol.87, pp.245-294, 2014. ,
DOI : 10.1016/B978-0-12-800149-3.00005-6
Dopaminergic Modulation of Visual Attention and Working Memory in the Rodent Prefrontal Cortex, Neuropsychopharmacology, vol.29, issue.9, pp.1628-1636, 2004. ,
DOI : 10.1038/sj.npp.1300490
Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy, Scientific Reports, vol.3, issue.2, p.7608, 2015. ,
DOI : 10.1124/jpet.106.104117
Medium-chain plasma acylcarnitines, ketone levels, cognition, and gray matter volumes in healthy elderly, mildly cognitively impaired, or Alzheimer's disease subjects, Neurobiology of Aging, vol.43, pp.1-12, 2016. ,
DOI : 10.1016/j.neurobiolaging.2016.03.005
P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model, J. Clin, 2005. ,
5-HT4 Receptors: Cloning and Expression of New Splice Variants, Annals of the New York Academy of Sciences, vol.87, issue.1 ADVANCES IN S, pp.49-56, 1998. ,
DOI : 10.1016/S0165-6147(00)89081-1
Novel brainspecific 5-HT4 receptor splice variants show marked constitutive activity: role of the Cterminal intracellular domain, Mol. Pharmacol, vol.55, pp.910-920, 1999. ,
Oxidative Stress and its Implications for Future Treatments and Management of Alzheimer Disease, Int. J. Biomed. Sci. IJBS, vol.6, pp.225-227, 2010. ,
Receptors Constitutively Promote the Non-Amyloidogenic Pathway of APP Cleavage and Interact with ADAM10, ACS Chemical Neuroscience, vol.4, issue.1, pp.130-140, 2013. ,
DOI : 10.1021/cn300095t
Evaluation of the effects of treatment with sAPP?? on functional and histological outcome following controlled cortical impact injury in mice, Neuroscience Letters, vol.515, issue.1, pp.50-54, 2012. ,
DOI : 10.1016/j.neulet.2012.03.017
Exploration of mice in a black and white test box: Validation as a model of anxiety, Pharmacology Biochemistry and Behavior, vol.32, issue.3, pp.777-785, 1989. ,
DOI : 10.1016/0091-3057(89)90033-6
Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations, Cochrane Database Syst. Rev, vol.21, issue.1, p.11145, 2016. ,
DOI : 10.1017/S0033291700014811
Tacrine: First Drug Approved for Alzheimer's Disease, Annals of Pharmacotherapy, vol.160, issue.6, pp.744-751, 1994. ,
DOI : 10.1192/bjp.160.1.36
Brain fuel metabolism, aging, and Alzheimer's disease. Nutr, Cty. Calif, vol.27, pp.3-20, 2011. ,
The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence, International Journal of Geriatric Psychiatry, vol.296, issue.S1, pp.23-32, 2003. ,
DOI : 10.1001/archneur.1986.00520100062016
Chronic 5-HT4 receptor agonist treatment restores learning and memory deficits in a neuroendocrine mouse model of anxiety/depression, Neuroscience Letters, vol.616, pp.197-203, 2016. ,
DOI : 10.1016/j.neulet.2016.01.055
antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate, British Journal of Pharmacology, vol.64, issue.1, pp.23-26, 2000. ,
DOI : 10.1038/sj.bjp.0703288
Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment, The Lancet Neurology, vol.2, issue.1, pp.15-21, 2003. ,
DOI : 10.1016/S1474-4422(03)00262-X
Spatial cognition and the human navigation network in AD and MCI, Neurology, vol.69, issue.10, pp.986-997, 2007. ,
DOI : 10.1212/01.wnl.0000271376.19515.c6
Soluble amyloid precursor protein alpha inhibits tau phosphorylation through modulation of GSK3?? signaling pathway, Journal of Neurochemistry, vol.31, issue.3, pp.630-637, 2015. ,
DOI : 10.1523/JNEUROSCI.3268-10.2011
Author response image 1. Effects are preserved across different searchlight sizes., eLife, vol.75, 2016. ,
DOI : 10.7554/eLife.16534.016
Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes, J. Virol, vol.65, pp.4759-4768, 1991. ,
Hyperforin prevents ??-amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer's amyloid-??-deposits, Molecular Psychiatry, vol.5, issue.11, pp.1032-1048, 2006. ,
DOI : 10.1073/pnas.182425199
Biased agonism at kappa opioid receptors: Implication in pain and mood disorders, European Journal of Pharmacology, vol.763, pp.184-190, 2015. ,
DOI : 10.1016/j.ejphar.2015.07.018
Non-Cholinergic Strategies for Treating and Preventing Alzheimer??s Disease, CNS Drugs, vol.19, issue.1, pp.811-824, 2002. ,
DOI : 10.2165/00023210-200216120-00003
The role of the N-methyl-D-aspartate receptor in Alzheimer???s disease: Therapeutic potential, Current Neurology and Neuroscience Reports, vol.306, issue.suppl, pp.373-378, 2003. ,
DOI : 10.1161/01.STR.26.4.602
A nonclassical 5- hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system, Mol. Pharmacol, vol.34, pp.880-887, 1988. ,
Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease, EMBO J, vol.7, pp.949-957, 1988. ,
Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease, JAMA, vol.311, issue.1, pp.33-44, 2014. ,
DOI : 10.1001/jama.2013.282834
Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer???s Disease, Disease Neuroimaging Initiative, pp.231-242, 2015. ,
DOI : 10.1017/S1355617708080387
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634634
Cleavage of amyloid beta peptide during constitutive processing of its precursor, Science, vol.248, issue.4959, pp.1122-1124, 1990. ,
DOI : 10.1126/science.2111583
Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor, Science, vol.255, issue.5045, pp.726-728, 1992. ,
DOI : 10.1126/science.1738846
Education and Other Measures of Socioeconomic Status and Risk of Incident Alzheimer Disease in a Defined Population of Older Persons, Archives of Neurology, vol.54, issue.11, pp.1399-1405, 1997. ,
DOI : 10.1001/archneur.1997.00550230066019
L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial, Human Psychopharmacology: Clinical and Experimental, vol.8, issue.Suppl 1, pp.351-359, 2014. ,
DOI : 10.1186/1472-6963-8-108
Multiple Defects in Energy Metabolism in Alzheimers Disease, Current Drug Targets, vol.11, issue.10, pp.1193-1206, 2010. ,
DOI : 10.2174/1389450111007011193
Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors, Clin. Interv. Aging, vol.8, pp.1007-1014, 2013. ,
The 5-HT6 Receptor Antagonist SB-271046 Reverses Scopolamine-Disrupted Consolidation of a Passive Avoidance Task and Ameliorates Spatial Task Deficits in Aged Rats, Neuropsychopharmacology, vol.29, issue.1, pp.93-100, 2004. ,
DOI : 10.1038/sj.npp.1300332
Worldwide Prevalence and Incidence of Dementia, Drugs & Aging, vol.15, issue.5, pp.365-375, 1999. ,
DOI : 10.2165/00002512-199915050-00004
Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members, Proc. Natl. Acad. Sci. U. S. A. 98, pp.3440-3445, 2001. ,
DOI : 10.1176/ajp.152.10.1485
Increased Activity-Regulating and Neuroprotective Efficacy of ??-Secretase-Derived Secreted Amyloid Precursor Protein Conferred by a C-Terminal Heparin-Binding Domain, Journal of Neurochemistry, vol.67, issue.5, pp.1882-1896, 1996. ,
DOI : 10.1046/j.1471-4159.1996.67051882.x
The Relationships Between Age, Sex, and the Incidence of Dementia and Alzheimer Disease, Archives of General Psychiatry, vol.55, issue.9, pp.809-815, 1998. ,
DOI : 10.1001/archpsyc.55.9.809
Alzheimer??s Disease associated with Psychiatric Comorbidities, Anais da Academia Brasileira de Ci??ncias, vol.11, issue.Suppl 1, pp.1461-1473, 2015. ,
DOI : 10.2174/1567205011666140812115004
URL : http://doi.org/10.1590/0001-3765201520140716
The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants, EMBO J, vol.14, pp.2806-2815, 1995. ,
Working Memory and Learning in Early Alzheimer?s Disease, Neuropsychology Review, vol.5, issue.1, pp.1-10, 2005. ,
DOI : 10.1111/j.1532-5415.1992.tb01992.x
Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer???s disease, Frontiers in Aging Neuroscience, vol.5, p.96, 2013. ,
DOI : 10.3389/fnagi.2013.00096
Long-term progression of Alzheimer???s disease in patients under antidementia drugs, Alzheimer's & Dementia, vol.7, issue.6, 2011. ,
DOI : 10.1016/j.jalz.2011.02.009
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochemical and Biophysical Research Communications, vol.120, issue.3, pp.885-890, 1984. ,
DOI : 10.1016/S0006-291X(84)80190-4
Therapeutic strategies for Alzheimer's disease in clinical trials, Pharmacological Reports, vol.68, issue.1, pp.127-138, 2016. ,
DOI : 10.1016/j.pharep.2015.07.006
Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer's disease, EMBO J, vol.6, pp.3627-3632, 1987. ,
[Role of the blood-brain barrier in Alzheimer's disease], Med. Sci. MS, vol.27, pp.987-992, 2011. ,
Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study, BMJ, vol.352, p.90, 2016. ,
DOI : 10.1136/bmj.i90
??-Amyloid-acetylcholine molecular interaction: new role of cholinergic mediators in anti-Alzheimer therapy?, Future Medicinal Chemistry, vol.8, issue.11, pp.1179-1189, 2016. ,
DOI : 10.4155/fmc-2016-0006
Restoring Soluble Amyloid Precursor Protein ?? Functions as a Potential Treatment for Alzheimer's Disease, Journal of Neuroscience Research, vol.368, issue.Suppl 2, 2016. ,
DOI : 10.1038/368635a0
Soluble ?amyloid Precursor Protein Alpha binds to p75 neurotrophin receptor to promote neurite outgrowth, PloS One, vol.8, 2013. ,
Molecular Mechanisms in the Pathogenesis of Alzheimer???s disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation, Biomolecules, vol.44, issue.2, 2016. ,
DOI : 10.1038/nrd4179
5-HT? receptor stimulation leads to soluble A?PP? production through MMP-9 upregulation, J. Alzheimers Dis. JAD, vol.32, pp.437-445, 2012. ,
The effect of estrogen replacement therapy on cognitive function in women: A critical review of the literature, Journal of Clinical Epidemiology, vol.50, issue.11, pp.1249-1264, 1997. ,
DOI : 10.1016/S0895-4356(97)00169-8
Diabetes Mellitus Is a Risk Factor for Vascular Dementia, but Not for Alzheimers Disease: A Population-Based Study of the Oldest Old, International Psychogeriatrics, vol.14, issue.3, pp.239-248, 2002. ,
DOI : 10.1017/S104161020200844X
Distribution of serotonin receptor 5-HT6 mRNA in rat neuronal subpopulations: A double in situ hybridization study, Neuroscience, vol.310, pp.442-454, 2015. ,
DOI : 10.1016/j.neuroscience.2015.09.064
Spatial Disorientation in Alzheimer's Disease, Archives of Neurology, vol.46, issue.4, pp.391-394, 1989. ,
DOI : 10.1001/archneur.1989.00520400045018
Increased misfolding and truncation of tau in APP/PS1/tau transgenic mice compared to mutant tau mice, Neurobiology of Disease, vol.62, pp.100-112, 2014. ,
DOI : 10.1016/j.nbd.2013.09.010
Differential regulation of amyloid-beta-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease., Proceedings of the National Academy of Sciences, vol.85, issue.4, pp.1297-1301, 1988. ,
DOI : 10.1073/pnas.85.4.1297
Evaluation and Management of the Elderly Patient Presenting with Cognitive Complaints, Medical Clinics of North America, vol.99, issue.2, pp.311-335, 2015. ,
DOI : 10.1016/j.mcna.2014.11.006
Differences in the Central Nervous System Distribution and Pharmacology of the Mouse 5-Hydroxytryptamine-6 Receptor Compared with Rat and Human Receptors Investigated by Radioligand Binding, Site-Directed Mutagenesis, and Molecular Modeling, Molecular Pharmacology, vol.64, issue.6, pp.1295-1308, 2003. ,
DOI : 10.1124/mol.64.6.1295
Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease, Biochemical Society Transactions, vol.23, issue.4, pp.891-897, 2011. ,
DOI : 10.1006/bbrc.2000.3763
Single-Chain Fragment Variable Passive Immunotherapies for Neurodegenerative Diseases, International Journal of Molecular Sciences, vol.7, issue.9, pp.19109-19127, 2013. ,
DOI : 10.1038/nchembio.582
URL : http://doi.org/10.3390/ijms140919109
Benzodiazepine Use and Risk of Developing Alzheimer???s Disease or Vascular Dementia: A Case???Control Analysis, Drug Safety, vol.3, issue.10, pp.909-919, 2015. ,
DOI : 10.1517/14740338.3.5.485
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers, The Lancet Neurology, vol.12, issue.2, pp.207-216, 2013. ,
DOI : 10.1016/S1474-4422(12)70291-0
Direct Electrical Stimulation of the Human Entorhinal Region and Hippocampus Impairs Memory, Neuron, vol.92, issue.5, pp.983-990, 2016. ,
DOI : 10.1016/j.neuron.2016.10.062
Memory loss in Alzheimer's disease, Dialogues Clin. Neurosci, vol.15, pp.445-454, 2013. ,
The C-Terminus of the ?? Protein is Critical in Amyloidogenesisa, Annals of the New York Academy of Sciences, vol.30, issue.1, pp.144-148, 1993. ,
DOI : 10.1021/bi00107a004
Low Cardiac Index Is Associated With Incident Dementia and Alzheimer Disease: The Framingham Heart Study, Circulation, vol.131, issue.15, pp.1333-1339, 2015. ,
DOI : 10.1161/CIRCULATIONAHA.114.012438
Alzheimer disease: Donepezil and nursing home placement ??? benefits and costs, Nature Reviews Neurology, vol.29, issue.1, pp.11-13, 2016. ,
DOI : 10.1007/s40266-012-0002-7
M1 muscarinic acetylcholine receptor in Alzheimer???s disease, Neuroscience Bulletin, vol.1, issue.Suppl4, pp.295-307, 2014. ,
DOI : 10.1021/cn900003h
Anti-inflammatory and anti-amyloidogenic effects of a small moleculebis(p-hydroxyphenyl)-2-butenal in Tg2576 Alzheimer's disease mice model, J. Neuroinflammation, vol.2, issue.10 2, 2013. ,
The 5-Hydroxytryptamine4 Receptor Agonists Prucalopride and PRX-03140 Increase Acetylcholine and Histamine Levels in the Rat Prefrontal Cortex and the Power of Stimulated Hippocampal ?? Oscillations, Journal of Pharmacology and Experimental Therapeutics, vol.341, issue.3, pp.681-691, 2012. ,
DOI : 10.1124/jpet.112.192351
UCP2 protects against amyloid beta toxicity and oxidative stress in primary neuronal culture, Biomedicine & Pharmacotherapy, vol.74, pp.211-214, 2015. ,
DOI : 10.1016/j.biopha.2015.08.001
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor, Nature, vol.325, issue.6106, pp.733-736, 1987. ,
DOI : 10.1038/325733a0
E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat, Psychopharmacology, vol.85, issue.2-3, pp.413-430, 2011. ,
DOI : 10.1016/j.pbb.2006.08.011
Gender differences in risk factors for transition from mild cognitive impairment to Alzheimer???s disease: A CREDOS study, Comprehensive Psychiatry, vol.62, pp.114-122, 2015. ,
DOI : 10.1016/j.comppsych.2015.07.002
Decreased plasma antioxidants in patients with Alzheimer's disease, International Journal of Geriatric Psychiatry, vol.3, issue.4, 2006. ,
DOI : 10.1016/0304-4165(87)90155-3
Neurotoxicity and Oxidative Damage of Beta Amyloid 1-42 versus Beta Amyloid 1-40 in the Mouse Cerebral Cortex, Annals of the New York Academy of Sciences, vol.826, issue.4, 1999. ,
DOI : 10.1016/S0006-8993(97)00383-1
The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies, Neuroscience & Biobehavioral Reviews, vol.34, issue.8, pp.1307-1350, 2010. ,
DOI : 10.1016/j.neubiorev.2010.04.001
Magnetic Resonance Imaging to Detect Early Molecular and Cellular Changes in Alzheimer's Disease. Front, Aging Neurosci, vol.8, p.139, 2016. ,
The Effects of Healthy Aging, Amnestic Mild Cognitive Impairment, and Alzheimer???s Disease on Recollection and Familiarity: A Meta-Analytic Review, Neuropsychology Review, vol.20, issue.11, pp.332-354, 2014. ,
DOI : 10.1002/hipo.20864
??-Amyloid efflux mediated by p-glycoprotein, Journal of Neurochemistry, vol.2, issue.4, pp.1121-1128, 2001. ,
DOI : 10.1042/bj3330621
Enhancement of place and object recognition memory in young adult and old rats by RS 67333, a partial agonist of 5-HT4 receptors, Neuropharmacology, vol.41, issue.7, pp.844-853, 2001. ,
DOI : 10.1016/S0028-3908(01)00123-X
Constitutive and regulated ??-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease, Proceedings of the National Academy of Sciences, vol.273, issue.48, pp.3922-3927, 1999. ,
DOI : 10.1074/jbc.273.48.31648
Design, synthesis and evaluation of novel tacrine-(??-carboline) hybrids as multifunctional agents for the treatment of Alzheimer???s disease, Bioorganic & Medicinal Chemistry, vol.22, issue.21, 2014. ,
DOI : 10.1016/j.bmc.2014.08.035
Interventions to delay functional decline in people with dementia: a systematic review of systematic reviews, BMJ Open, vol.28, issue.(2), 2016. ,
DOI : 10.1002/gps.3864
Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment, Proc. Natl. Acad. Sci. U. S. A. 111, pp.3825-3830, 2014. ,
DOI : 10.1016/0006-2952(61)90145-9
BIMU 1 and RS 67333, two 5-HT4 receptor agonists, modulate spontaneous alternation deficits induced by scopolamine in the mouse, Naunyn-Schmiedeberg's Archives of Pharmacology, vol.367, issue.6, pp.621-628, 2003. ,
DOI : 10.1007/s00210-003-0743-2
Chronic Glutamate Toxicity in Neurodegenerative Diseases???What is the Evidence?, Frontiers in Neuroscience, vol.145, issue.165, p.469, 2015. ,
DOI : 10.1016/j.cell.2011.05.020
Pathophysiological amyloid concentrations induce sustained upregulation of readthrough acetylcholinesterase mediating anti-apoptotic effects, Neuroscience, vol.240, pp.349-360, 2013. ,
DOI : 10.1016/j.neuroscience.2013.02.040
The sleep???wake cycle and Alzheimer's disease: what do we know?, Neurodegenerative Disease Management, vol.4, issue.5, pp.351-362, 2014. ,
DOI : 10.2217/nmt.14.33
Design, synthesis and pharmacological evaluation of chalcone derivatives as acetylcholinesterase inhibitors, Bioorganic & Medicinal Chemistry, vol.22, issue.21, 2014. ,
DOI : 10.1016/j.bmc.2014.08.033
Expression and function of 5-HT4 receptors in the mouse enteric nervous system, AJP: Gastrointestinal and Liver Physiology, vol.289, issue.6, pp.1148-1163, 2005. ,
DOI : 10.1152/ajpgi.00245.2005
Bis(9)-(???)-nor-meptazinol as a novel dual-binding AChEI potently ameliorates scopolamine-induced cognitive deficits in mice, Pharmacology Biochemistry and Behavior, vol.104, pp.138-143, 2013. ,
DOI : 10.1016/j.pbb.2012.11.009
SSP-002392, a new 5-HT4 receptor agonist, dose-dependently reverses scopolamine-induced learning and memory impairments in C57Bl/6 mice, Neuropharmacology, vol.85, pp.178-189, 2014. ,
DOI : 10.1016/j.neuropharm.2014.05.013
Cerebral serotonin 4 receptors and amyloid-? in early Alzheimer's disease, J. Alzheimers Dis. JAD, vol.26, pp.457-466, 2011. ,
New multi-target-directed small molecules against Alzheimer's disease: a combination of resveratrol and clioquinol, Organic & Biomolecular Chemistry, vol.38, issue.31, pp.5936-5944, 2014. ,
DOI : 10.1016/S0223-5234(03)00012-6
receptor-mediated acetylcholine release, European Journal of Neuroscience, vol.114, issue.5, pp.1299-1306, 2006. ,
DOI : 10.1111/j.1460-9568.2006.05003.x
Involvement of an Altered 5-HT6 Receptor Function in Behavioral Symptoms of Alzheimer's Disease, Journal of Alzheimer's Disease, vol.14, issue.1, pp.43-50, 2008. ,
DOI : 10.3233/JAD-2008-14104
Effects of 5-HT6 receptor antagonism and cholinesterase inhibition in models of cognitive impairment in the rat, British Journal of Pharmacology, vol.3, issue.3, pp.434-440, 2008. ,
DOI : 10.1007/s00213-003-1683-8
Cleavage at the N-Terminal Site of Alzheimer Amyloid ??/A4 Protein Is Essential for Its Secretion, Biochemical and Biophysical Research Communications, vol.202, issue.3, pp.1517-1523, 1994. ,
DOI : 10.1006/bbrc.1994.2103
Clinical Benefits of Memantine Treatment for Alzheimer???s Disease in the Okayama Memantine Study II (OMS II), Journal of Alzheimer's Disease, vol.350, issue.2, pp.487-493, 2015. ,
DOI : 10.1007/s00415-006-0374-x
Memory Dysfunction, CONTINUUM: Lifelong Learning in Neurology, vol.21, pp.613-626, 2015. ,
DOI : 10.1212/01.CON.0000466656.59413.29
Decreased Clearance of CNS ??-Amyloid in Alzheimer's Disease, Science, vol.46, issue.6, p.1774, 2010. ,
DOI : 10.1212/WNL.46.6.1592
Risk of Dementia in First-Degree Relatives of Patients With Alzheimer's Disease and Related Disorders, Archives of Neurology, vol.48, issue.3, pp.269-273, 1991. ,
DOI : 10.1001/archneur.1991.00530150037014
The effects of the 5-HT6 receptor agonist EMD and the 5-HT7 receptor agonist AS19 on memory formation, Behavioural Brain Research, vol.195, issue.1, pp.112-119, 2008. ,
DOI : 10.1016/j.bbr.2007.11.023
Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease, Journal of Comparative Neurology, vol.313, issue.Suppl, pp.4124-4144, 2013. ,
DOI : 10.1002/cne.903130207
Attenuating A??1???42-induced toxicity by a novel acetylcholinesterase inhibitor, Neuroscience, vol.250, pp.309-319, 2013. ,
DOI : 10.1016/j.neuroscience.2013.07.014
BGC20-761, a novel tryptamine analog, enhances memory consolidation and reverses scopolamine-induced memory deficit in social and visuospatial memory tasks through a 5-HT6 receptor-mediated mechanism, Neuropharmacology, vol.50, issue.4, pp.412-420, 2006. ,
DOI : 10.1016/j.neuropharm.2005.10.002
Adaptations in 5-HT receptor expression and function: Implications for treatment of cognitive impairment in aging, Journal of Neuroscience Research, vol.41, issue.12, pp.2803-2811, 2009. ,
DOI : 10.1093/gerona/54.11.B492
VRX-03011, a novel 5-HT4 agonist, enhances memory and hippocampal acetylcholine efflux, Neuropharmacology, vol.53, issue.4, pp.563-573, 2007. ,
DOI : 10.1016/j.neuropharm.2007.06.016
Efficacy of Memantine, Donepezil, or Their Association in Moderate-Severe Alzheimer???s Disease: A Review of Clinical Trials, The Scientific World Journal, vol.14, issue.2, p.925702, 2013. ,
DOI : 10.2147/ciia.2006.1.2.143
NR2B subunit in the prefrontal cortex: A double-edged sword for working memory function and psychiatric disorders, Neuroscience & Biobehavioral Reviews, vol.56, pp.127-138, 2015. ,
DOI : 10.1016/j.neubiorev.2015.06.022
Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs, 1993. ,
Mass spectrometry of purified amyloid beta protein in Alzheimer's disease, J. Biol. Chem, vol.267, pp.17082-17086, 1992. ,
A new design for the screening of CNS-active drugs in mice. A multidimensional observation procedure and the study of pharmacological interactions, 1971. ,
Protection of Flupirtine on ??-Amyloid-Induced Apoptosis in Neuronal Cells In Vitro: Prevention of Amyloid-Induced Glutathione Depletion, Journal of Neurochemistry, vol.68, issue.6, pp.2371-2377, 1997. ,
DOI : 10.1046/j.1471-4159.1997.68062371.x
Sex differences in Alzheimer's disease risk: are we looking at the wrong hormones?, International Psychogeriatrics, vol.17, issue.10, pp.1579-1584, 2014. ,
DOI : 10.1016/S0018-506X(02)00022-3
Multimodality Imaging of Alzheimer Disease and Other Neurodegenerative Dementias, Journal of Nuclear Medicine, vol.55, issue.12, 2003. ,
DOI : 10.2967/jnumed.114.141416
Multitarget Drug Design Strategy: Quinone???Tacrine Hybrids Designed To Block Amyloid-?? Aggregation and To Exert Anticholinesterase and Antioxidant Effects, Journal of Medicinal Chemistry, vol.57, issue.20, 2014. ,
DOI : 10.1021/jm5010804
Vascular risk factors and Alzheimer's disease, BMC Med, vol.12, p.218, 2014. ,
Intraneuronal beta-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation, Journal of Neuroscience, vol.26, issue.40, pp.10129-10140, 2006. ,
DOI : 10.1523/JNEUROSCI.1202-06.2006
Changes in Plasticity Across the Lifespan, Prog. Brain Res, vol.207, pp.91-120, 2013. ,
DOI : 10.1016/B978-0-444-63327-9.00016-3
Soluble amyloid precursor protein-?? modulates ??-secretase activity and amyloid-?? generation, Nature Communications, vol.18, p.777, 2012. ,
DOI : 10.1523/JNEUROSCI.3268-10.2011
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520614
Assessment of risk factors for earlier onset of sporadic Alzheimer???s disease dementia, Neurology India, vol.62, issue.6, pp.625-630, 2014. ,
DOI : 10.4103/0028-3886.149384
Acquisition, Retention, and Recall of Memory After Injection of RS67333, a 5-HT4 Receptor Agonist, Into the Nucleus Basalis Magnocellularis of the Rat, Learning & Memory, vol.10, issue.5, pp.420-426, 2003. ,
DOI : 10.1101/lm.67303
Protective effects of NMDA receptor antagonist, memantine, against senescence of PC12 cells: A possible role of nNOS and combined effects with donepezil, Experimental Gerontology, vol.72, pp.109-116, 2015. ,
DOI : 10.1016/j.exger.2015.09.016
Topographical disorientation in community-residing patients with Alzheimer's disease, International Journal of Geriatric Psychiatry, vol.19, issue.3, pp.250-255, 2004. ,
DOI : 10.1002/gps.1081
Earlyonset Alzheimer's disease: a global cross-sectional analysis, Y., and the Coalition against Major Diseases (CAMD), 2014. ,
Interactions between A?? oligomers and presynaptic cholinergic signaling: Age-dependent effects on attentional capacities, Behavioural Brain Research, vol.274, pp.30-42, 2014. ,
DOI : 10.1016/j.bbr.2014.07.046
A??1???42 reduces P-glycoprotein in the blood???brain barrier through RAGE???NF-??B signaling, Cell Death and Disease, vol.276, issue.6, 1299. ,
DOI : 10.1097/00001756-199904260-00035
Cotinine halts the advance of Alzheimer's disease-like pathology and associated depressive-like behavior in Tg6799 mice, Frontiers in Aging Neuroscience, vol.228, issue.173, p.162, 2014. ,
DOI : 10.1016/j.bbr.2011.11.023
Serotonin 5-HT4 receptors and forebrain cholinergic system: receptor expression in identified cell populations, Brain Structure and Function, vol.65, issue.6, pp.3413-3434, 2015. ,
DOI : 10.1016/0014-4886(79)90255-3
Oral administration of the 5-HT receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task, Pharmacology Biochemistry and Behavior, vol.81, issue.3, pp.673-682, 2005. ,
DOI : 10.1016/j.pbb.2005.05.005
Differential Processing of Amyloid-?? Precursor Protein Directs Human Embryonic Stem Cell Proliferation and Differentiation into Neuronal Precursor Cells, Journal of Biological Chemistry, vol.40, issue.35, pp.23806-23817, 2009. ,
DOI : 10.1016/S0896-6273(02)00604-9
Cholinergic circuits in cognitive flexibility, Neuroscience, vol.345, 2016. ,
DOI : 10.1016/j.neuroscience.2016.09.013
5-HT6 receptor antagonists as treatment for age-related cognitive decline, Reviews in the Neurosciences, vol.25, issue.3, pp.417-427, 2014. ,
DOI : 10.1515/revneuro-2014-0013
Exercise, oxidative stress and hormesis, Ageing Research Reviews, vol.7, issue.1, pp.34-42, 2008. ,
DOI : 10.1016/j.arr.2007.04.004
Vitamin D2 suppresses amyloid-? 25-35 induced microglial activation, BV2 cells by blocking the NF-?B inflammatory signaling pathway, 2016. ,
Serotonergic Therapies for Cognitive Symptoms in Alzheimer???s Disease: Rationale and Current Status, Drugs, vol.10, issue.4, pp.729-736, 2014. ,
DOI : 10.2174/1567205011310040007
The Secreted ??-Amyloid Precursor Protein Ectodomain APPs?? Is Sufficient to Rescue the Anatomical, Behavioral, and Electrophysiological Abnormalities of APP-Deficient Mice, Journal of Neuroscience, vol.27, issue.29, pp.7817-7826, 2007. ,
DOI : 10.1523/JNEUROSCI.1026-07.2007
2-Arylbenzofuran-based molecules as multipotent Alzheimer's disease modifying agents, European Journal of Medicinal Chemistry, vol.58, pp.519-532, 2012. ,
DOI : 10.1016/j.ejmech.2012.10.045
The Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease: Results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial, Dementia and Geriatric Cognitive Disorders, vol.7, issue.6, pp.293-303, 1996. ,
DOI : 10.1159/000106895
receptor antagonist, British Journal of Pharmacology, vol.62, issue.7, pp.1606-1612, 2000. ,
DOI : 10.1038/sj.bjp.0703457
A Novel Rat Serotonin (5-HT6) Receptor: Molecular Cloning, Localization and Stimulation of cAMP Accumulation, Biochemical and Biophysical Research Communications, vol.193, issue.1, pp.268-276, 1993. ,
DOI : 10.1006/bbrc.1993.1619
Characterization of Oligomers of Heterogeneous Size as Precursors of Amyloid Fibril Nucleation of an SH3 Domain: An Experimental Kinetics Study, PLoS ONE, vol.71, issue.11, p.49690, 2012. ,
DOI : 10.1371/journal.pone.0049690.s009
Time-dependent changes in gene expression induced by secreted amyloid precursor protein-alpha in the rat hippocampus, BMC Genomics, vol.14, issue.1, p.376, 2013. ,
DOI : 10.1177/002215549904700311
Biperiden selectively induces memory impairment in healthy volunteers: no interaction with citalopram, Psychopharmacology, vol.97, issue.11, pp.1887-1897, 2015. ,
DOI : 10.1016/j.pneurobio.2012.02.002
Amyloid-? peptides are generated in mitochondria-associated endoplasmic reticulum membranes, J. Alzheimers Dis. JAD, vol.43, pp.369-374, 2015. ,
The role of egocentric and allocentric abilities in Alzheimer's disease: A systematic review, Ageing Research Reviews, vol.16, pp.32-44, 2014. ,
DOI : 10.1016/j.arr.2014.04.004
Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies, Neurotoxicology, vol.12, pp.473-492, 1991. ,
Exploring Biomarkers for Alzheimer???s Disease, JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2016. ,
DOI : 10.7860/JCDR/2016/18828.8166
5-HT4 receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessment, Neuropharmacology, vol.61, issue.1-2, pp.69-79, 2011. ,
DOI : 10.1016/j.neuropharm.2011.02.026
Short-term memory: A brief commentary, Memory & Cognition, vol.21, issue.2, pp.193-197, 1993. ,
DOI : 10.3758/BF03202729
Selective 5-HT6 Receptor Blockade Improves Spatial Recognition Memory and Reverses Age-Related Deficits in Spatial Recognition Memory in the Mouse, Neuropsychopharmacology, vol.321, issue.2, pp.488-500, 2009. ,
DOI : 10.1007/s00213-003-1552-5
URL : https://hal.archives-ouvertes.fr/hal-00863265
Serotonin 5-HT6 receptor blockade reverses the age-related deficits of recognition memory and working memory in mice, Behavioural Brain Research, vol.222, issue.1, 2011. ,
DOI : 10.1016/j.bbr.2011.03.046
URL : https://hal.archives-ouvertes.fr/hal-00862995
5-HT6 receptor blockade differentially affects scopolamine-induced deficits of working memory, recognition memory and aversive learning in mice, Psychopharmacology, vol.44, issue.2, pp.99-115, 2012. ,
DOI : 10.1016/j.jpba.2007.02.024
URL : https://hal.archives-ouvertes.fr/hal-00862409
Monoaminergic neuropathology in Alzheimer???s disease, Progress in Neurobiology, vol.151, 2016. ,
DOI : 10.1016/j.pneurobio.2016.04.001
Diagnosis and Treatment of Alzheimer Disease and Related Disorders, Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society, pp.1363-1371, 1997. ,
DOI : 10.1001/jama.1997.03550160083043
Possible biochemical basis of memory disorder in Alzheimer disease, Annals of Neurology, vol.2, issue.6, pp.471-473, 1978. ,
DOI : 10.1001/archneur.1977.00500160029004
Pelargonidin Improves Passive Avoidance Task Performance in a Rat Amyloid Beta25-35 Model of Alzheimer's Disease Via Estrogen Receptor Independent Pathways, Acta Med. Iran, vol.54, pp.245-250, 2016. ,
Accumulation of amyloid-?? by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons, Molecular Neurodegeneration, vol.58, issue.1, p.38, 2016. ,
DOI : 10.1002/ana.20524
The Impact of Age-Related Changes on Working Memory Functional Activity, Brain Imaging and Behavior, vol.14, issue.10, pp.142-153, 2009. ,
DOI : 10.1212/WNL.37.2.179
Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients, Neuroscience Letters, vol.203, issue.1, pp.29-32, 1996. ,
DOI : 10.1016/0304-3940(95)12256-7
Aging and the Occurrence of Dementia, Archives of Neurology, vol.56, issue.5, pp.587-592, 1999. ,
DOI : 10.1001/archneur.56.5.587
Aph-1, Pen-2, and Nicastrin with Presenilin Generate an Active ??-Secretase Complex, Neuron, vol.38, issue.1, pp.9-12, 2003. ,
DOI : 10.1016/S0896-6273(03)00205-8
Oxidative stress in Alzheimer's disease: Primary villain or physiological by-product?, Redox Report, vol.5, issue.2, pp.134-141, 2013. ,
DOI : 10.3233/JAD-2010-1390
Alzheimer's disease amyloid ??-clipping enzyme (APP secretase): Identification, purification, and characterization of the enzyme, Biochemical and Biophysical Research Communications, vol.177, issue.1, pp.377-387, 1991. ,
DOI : 10.1016/0006-291X(91)91994-N
Three types of amyloid protein precursor mRNA in human brain: Their differential expression in Alzheimer's disease, Biochemical and Biophysical Research Communications, vol.157, issue.2, pp.472-479, 1988. ,
DOI : 10.1016/S0006-291X(88)80273-0
Decreased striatal D2 receptor density associated with severe behavioral abnormality in Alzheimer???s disease, Annals of Nuclear Medicine, vol.31, issue.2, pp.567-573, 2003. ,
DOI : 10.1212/WNL.55.2.205
Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus, Science, vol.235, issue.4791, pp.880-884, 1987. ,
DOI : 10.1126/science.2949367
Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving Donepezil, JAMA, vol.291, issue.3, pp.317-324, 2004. ,
DOI : 10.1001/jama.291.3.317
Cholinergic System Dysfunction and Neurodegenerative Diseases: Cause or Effect?, CNS & Neurological Disorders - Drug Targets, vol.13, issue.7, pp.1294-1303, 2014. ,
DOI : 10.2174/1871527313666140917121132
Endogenous secreted amyloid precursor protein-?? regulates hippocampal NMDA receptor function, long-term potentiation and spatial memory, Neurobiology of Disease, vol.31, issue.2, pp.250-260, 2008. ,
DOI : 10.1016/j.nbd.2008.04.011
Omega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer???s Disease, BioMed Research International, vol.77, issue.4, 2015. ,
DOI : 10.1136/jnnp-2012-304792
Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study, BMJ Open, vol.6, issue.7, 2016. ,
DOI : 10.1136/bmjopen-2016-012100
Oxidative stress, protein modification and Alzheimer disease, Brain Research Bulletin, vol.133, 2016. ,
DOI : 10.1016/j.brainresbull.2016.06.005
Type 2 Diabetes as a Risk Factor for Alzheimer's Disease: The Confounders, Interactions, and Neuropathology Associated With This Relationship, Epidemiologic Reviews, vol.35, issue.1, pp.152-160, 2013. ,
DOI : 10.1093/epirev/mxs012
The role of conformational ensembles of seven transmembrane receptors in functional selectivity, Current Opinion in Pharmacology, vol.10, issue.6, pp.775-781, 2010. ,
DOI : 10.1016/j.coph.2010.09.004
Beta-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE, Science, vol.286, issue.5440, pp.735-741, 1999. ,
DOI : 10.1126/science.286.5440.735
Gender, sex steroid hormones, and Alzheimer's disease, Hormones and Behavior, vol.63, issue.2, 2013. ,
DOI : 10.1016/j.yhbeh.2012.04.006
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413783
Measuring serotonin synthesis: from conventional methods to PET tracers and their (pre)clinical implications, European Journal of Nuclear Medicine and Molecular Imaging, vol.27, issue.2, pp.576-591, 2011. ,
DOI : 10.1016/j.jchemneu.2004.02.003
Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models, Frontiers in Genetics, vol.45, p.88, 2014. ,
DOI : 10.1016/j.neuron.2005.01.040
Activation of the 5-HT6 receptor attenuates long-term potentiation and facilitates GABAergic neurotransmission in rat hippocampus, Neuroscience, vol.164, issue.2, pp.692-701, 2009. ,
DOI : 10.1016/j.neuroscience.2009.07.061
The worldwide economic impact of dementia 2010, Alzheimer's & Dementia, vol.9, issue.1, 2013. ,
DOI : 10.1016/j.jalz.2012.11.006
Identification of Low Molecular Weight Pyroglutamate A?? Oligomers in Alzheimer Disease, Journal of Biological Chemistry, vol.5, issue.53, pp.41517-41524, 2010. ,
DOI : 10.1146/annurev.neuro.31.060407.125529
Characterization of [3H]GR 113808 binding to 5-HT4 receptors in brain tissues from patients with neurodegenerative disorders, Behavioural Brain Research, vol.73, issue.1-2, pp.249-252, 1996. ,
DOI : 10.1016/0166-4328(96)00106-4
-adrenoceptor, British Journal of Pharmacology, vol.75, issue.Suppl. 1, pp.5477-5488, 2015. ,
DOI : 10.1124/mol.108.052399
URL : https://hal.archives-ouvertes.fr/hal-01405474
5-HT6 receptor agonists and antagonists enhance learning and memory in a conditioned emotion response paradigm by modulation of cholinergic and glutamatergic mechanisms, British Journal of Pharmacology, vol.285, issue.2, pp.436-449, 2012. ,
DOI : 10.1074/jbc.M109.068759
5-ht6 Receptors, Current Drug Target -CNS & Neurological Disorders, vol.3, issue.1, pp.59-79, 2004. ,
DOI : 10.2174/1568007043482561
The Association Between Dementia and Long-Term Use of Benzodiazepine in the Elderly: Nested Case???Control Study Using Claims Data, The American Journal of Geriatric Psychiatry, vol.17, issue.7, pp.614-620, 2009. ,
DOI : 10.1097/JGP.0b013e3181a65210
Effects and mechanism of lipoic acid on beta-amyloid-intoxicated C6 glioma cells, Genetics and Molecular Research, vol.14, issue.4, pp.13880-13888, 2015. ,
DOI : 10.4238/2015.October.29.8
Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer???s disease, European Journal of Medicinal Chemistry, vol.121, pp.283-293, 2016. ,
DOI : 10.1016/j.ejmech.2016.05.048
Cholinergic receptors: functional role of nicotinic ACh receptors in brain circuits and disease. Pflügers Arch. Eur, J. Physiol, vol.465, pp.441-450, 2013. ,
Gender Differences: A Lifetime Analysis of the Economic Burden of Alzheimer's Disease, Women's Health Issues, vol.25, issue.5, pp.436-440, 2015. ,
DOI : 10.1016/j.whi.2015.06.001
Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease, Science, vol.245, issue.4916, pp.417-420, 1989. ,
DOI : 10.1126/science.2474201
Central Distribution and Function of 5-ht6 Receptor Subtype in the Rat Brain, Annals of the New York Academy of Sciences, vol.43, issue.1 ADVANCES IN S, p.244, 1998. ,
DOI : 10.1111/j.1749-6632.1998.tb10201.x
Development of a liquid chromatography/tandem mass spectrometry method for the quantitation of acetylcholine and related neurotransmitters in brain microdialysis samples, Journal of Pharmaceutical and Biomedical Analysis, vol.44, issue.2, pp.586-593, 2007. ,
DOI : 10.1016/j.jpba.2007.02.024
Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer???s disease, Nature Communications, vol.13, issue.8762, 2015. ,
DOI : 10.1038/npp.2013.243
Asparagine endopeptidase is an innovative therapeutic target for neurodegenerative diseases, Expert Opinion on Therapeutic Targets, vol.31, issue.3, pp.1237-1245, 2016. ,
DOI : 10.1038/jcbfm.2012.126
Inflammation in Alzheimer???s Disease and Molecular Genetics: Recent Update, Archivum Immunologiae et Therapiae Experimentalis, vol.6, issue.Pt 11, pp.333-344, 2015. ,
DOI : 10.1101/gad.6.9.1783
Wnt / ??-Catenin Signaling Pathway Against A?? Toxicity in PC12 Cells, Neurosignals, vol.24, pp.40-47, 2016. ,
DOI : 10.1159/000442610
Smoking Is Associated with an Increased Risk of Dementia: A Meta-Analysis of Prospective Cohort Studies with Investigation of Potential Effect Modifiers, PLOS ONE, vol.135, issue.1, 2015. ,
DOI : 10.1371/journal.pone.0118333.s004
Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and ??-secretase, Bioorganic & Medicinal Chemistry, vol.17, issue.4, pp.1600-1613, 2009. ,
DOI : 10.1016/j.bmc.2008.12.067
Acetylcholine and the alpha 7 nicotinic receptor: a potential therapeutic target for the treatment of periodontal disease?, Inflammation Research, vol.130, issue.2, 2012. ,
DOI : 10.1007/s00418-008-0455-2